Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Hemann, Michael T."'
Autor:
Vassel FM; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139., Bian K; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139., Walker GC; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; gwalker@mit.edu hemann@mit.edu., Hemann MT; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; gwalker@mit.edu hemann@mit.edu.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Nov 17; Vol. 117 (46), pp. 28922-28924. Date of Electronic Publication: 2020 Nov 03.
Autor:
Wojtaszek JL; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA., Chatterjee N; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Najeeb J; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA., Ramos A; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Lee M; Department of Chemistry, Duke University, Durham, NC 27708, USA., Bian K; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA., Xue JY; Trinity College of Arts & Sciences, Duke University, Durham, NC 27708, USA., Fenton BA; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA., Park H; Department of Chemistry, Duke University, Durham, NC 27708, USA., Li D; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA., Hemann MT; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: hemann@mit.edu., Hong J; Department of Chemistry, Duke University, Durham, NC 27708, USA; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: jiyong.hong@duke.edu., Walker GC; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: gwalker@mit.edu., Zhou P; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: peizhou@biochem.duke.edu.
Publikováno v:
Cell [Cell] 2019 Jun 27; Vol. 178 (1), pp. 152-159.e11. Date of Electronic Publication: 2019 Jun 06.
Autor:
Qi R; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Wang Y; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Bruno PM; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Xiao H; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Yu Y; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Li T; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.; Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA., Lauffer S; Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA., Wei W; Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA., Chen Q; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Kang X; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Song H; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Yang X; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Huang X; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Detappe A; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.; Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA., Matulonis U; Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA., Pepin D; Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA., Hemann MT; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA., Birrer MJ; Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. mbirrer@mgh.harvard.edu.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. mbirrer@mgh.harvard.edu., Ghoroghchian PP; Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA. ppg@mit.edu.; Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. ppg@mit.edu.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. ppg@mit.edu.
Publikováno v:
Nature communications [Nat Commun] 2017 Dec 18; Vol. 8 (1), pp. 2166. Date of Electronic Publication: 2017 Dec 18.
Autor:
Bruno PM; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Liu Y; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Park GY; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Murai J; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Koch CE; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Eisen TJ; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Howard Hughes Medical Institute, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Pritchard JR; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Lippard SJ; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Hemann MT; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Publikováno v:
Nature medicine [Nat Med] 2017 Apr; Vol. 23 (4), pp. 461-471. Date of Electronic Publication: 2017 Feb 27.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Murai, Junko, Pommier, Yves, Hemann, Michael T, Bruno, Peter Michael, Liu, Yunpeng, Park, Ga Young, Koch, Catherine E., Lippard, Stephen J., Hemann, Michael, Eisen, Timothy Jonas, Pritchard, Justin R.
Publikováno v:
PMC
Cisplatin and its platinum analogs, carboplatin and oxaliplatin, are some of the most widely used cancer chemotherapeutics. Although cisplatin and carboplatin are used primarily in germ cell, breast and lung malignancies, oxaliplatin is instead used
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruogu Qi, Yongheng Wang, Bruno, Peter M., Haihua Xiao, Yingjie Yu, Ting Li, Lauffer, Sam, Wei Wei, Qixian Chen, Xiang Kang, Haiqin Song, Xi Yang, Xing Huang, Detappe, Alexandre, Matulonis, Ursula, Pepin, David, Hemann, Michael T., Birrer, Michael J., Peter Ghoroghchian, P.
Publikováno v:
Nature Communications; 12/18/2017, Vol. 8 Issue 1, p1-12, 12p